2009
Delhi (India)
Series E
DCDC Kidney Care is right at the center of making that access easier.The company has quietly grown into one of the country’s dialysis providers. With a presence in over 200 centers across India, they serve more than 20,000 patients annually—and they’re still expanding. The healthcare industry in India faces many gaps, especially when it comes to chronic conditions like end-stage renal disease (ESRD). DCDC focuses entirely on this space.They’ve joined hands with state governments to offer affordable or subsidized treatments to lower-income communities—bringing critical care to patients who would otherwise be left behind.
$61.7 Million
7
$17.4 Million, Series E
as of March 24, 2025
$29.8 Million
as of February 29, 2024
0.86
as of February 29, 2024
ABC Impact
and 2 more559
The Eye Vet
N/A
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
March 24, 2025 | Series E | $17.4 Million | - | - | - | ABC Impact |
December 9, 2024 | Series D | $9.7 Million | - | - | - | British International Investment |
February 29, 2024 | Series C | $1.6 Million | $29.8 Million | $14.1 Million | - | IFU |
March 1, 2023 | Series C | $3.8M | $28.4M | $10 Million | - | IFU |
December 28, 2020 | Series C | $21.5 Million | - | $8.3 Million | - | IFU |
August 30, 2018 | Series B | $3.2 Million | $17.9 Million | $5.1 Million | - | Asian Development Bank |
September 10, 2014 | Series A | $4.4 Million | $12.5 Million | - | - | Pragati Capital |